Similar articles

• Management of cirrhosis and ascites.

  Ginès P, Cárdenas A, Arroyo V, Rodés J. Ginès P, et al. N Engl J Med. 2004 Apr 15;350(16):1646-54. doi: 10.1056/NEJMra035021. N Engl J Med. 2004. PMID: 15084697 Review. No abstract available.
• EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

  European Association for the Study of the Liver. European Association for the Study of the Liver. J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1. J Hepatol. 2010. PMID: 20633946 Review. No abstract available.
• Refractory ascites: definition and mechanism.

  Arroyo V, Badalamenti S, Ginès P. Arroyo V, et al. Minerva Med. 1987 May 31;78(10):675-80. Minerva Med. 1987. PMID: 3587714 No abstract available.
• Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

  Arroyo V, Colmenero J. Arroyo V, et al. J Hepatol. 2003;38 Suppl 1:S69-89. doi: 10.1016/s0168-8278(03)00007-2. J Hepatol. 2003. PMID: 12591187 Review. No abstract available.
• Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.

  Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS. Salerno F, et al. Liver Int. 2010 Aug;30(7):937-47. doi: 10.1111/j.1478-3231.2010.02272.x. Epub 2010 May 21. Liver Int. 2010. PMID: 20492521 Review.